Inhibitory effect of interleukin-16 on interleukin-2 production by CD4 + T cells

Immunology

Volumn 96, Issue 2, 1999, Pages 215-219

  Ogasawara, H ^a   Takeda Hirokawa, N ^a   Sekigawa, Iwao ^b,d   Hashimoto, H ^a   Kaneko, Y ^c   Hirose, S ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c AJINOMOTO CO INC   (Japan)

^d JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; CYTOKINE RECEPTOR; EPITOPE; GLYCOPROTEIN GP 120; INTERLEUKIN 16; INTERLEUKIN 2;

ARTICLE; BINDING SITE; CELL CYCLE; CELL DIVISION; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIBODIES; ANTIGENS, CD4; ANTIGENS, CD8; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CLONAL ANERGY; CONCANAVALIN A; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ENVELOPE PROTEIN GP120; HUMANS; INTERLEUKIN-16; INTERLEUKIN-2;

EID: 0032925019     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00693.x     Document Type: Article

References (36)

1. 1. CENTER D.M. & CRUIKSHANK W.W. (1982) Modulation of lymphocyte migration by human lymphokines. J Immunol 128, 2563.
2. 2. CRUIKSHANK W.W. & CENTER D.M. (1982) Modulation of lymphocyte migration by human lymphokines. Purification of a lymphotactic factor (LCF). J Immunol 128, 2569.
3. + T lymphocytes and monocytes. J Immunol 138, 3817.
4. 4. RAND T.H., CRUIKSHANK W.W., CENTER D.M. & WELLER P.F. (1991) CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit cosinophil migration. J Exp Med 173, 1521.
5. 5. CRUIKSHANK W.W., CENTER D.M., NISAR N. et al. (1991) Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA 91, 5109.
6. 6. THEODORE A.C., CENTER D.M., NICOLL J., FINE G., KORNFELD H. & CRUIKSHANK W.W. (1996) CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J Immunol 157, 1958.
7. 7. CRUIKSHANK W.W., LIM K., THEODORE A.C. et al. (1996) IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol 157, 5240.
8. 8. CENTER D.M., KORNFELD H. & CRUIKSHANK W.W. (1996) Interleukin-16 and its function as a CD4 ligand. Immunol Today 17, 476.
9. 9. WANG J., YAN Y., GARRETT T.P.J. et al. (1990) Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348, 411.
10. 10. KWONG P.D., RYU S.E., HENDRICKSON W.A. et al. (1990) Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals. Proc Natl Acad Sci USA 87, 6423.
11. 11. SAKIHAMA T., SMOLYAR A. & REINHERZ E.L. (1995) Oligomerization of CD4 is required for stable binding to class major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc Natl Acad Sci USA 92, 6444.
12. + T cell anergy. Clin Exp Immunol 109, 41.
13. 13. SEKIGAWA I., GROOPMAN J.E., ALLAN J.D. et al. (1991) Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clin Immunol Immunopathol 58, 145.
14. 14. NEOH L.P., AKIMOTO H., KANEKO H. et al. (1997) The production of beta-chemokines induced by HIV-2 envelope glycoprotein. AIDS 11, 1062.
15. 15. KANEKO H., NEOH L.P., TAKEDA N. et al. (1997) Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cell. J Virol 71, 8918.
16. 16. SNOW P., SPITS H., DE VRIES J. & TERHORST C. (1983) Comparison of target antigens of monoclonal reagents OKT5, OKT8 and Leu2A, which inhibit effector function of human cytotoxic T lymphocytes. Hybridoma 2, 187.
17. 17. BAIER M., WERNER A., BANNERT N., METZNER K. & KURTH R. (1995) HIV suppression by interleukin-16. Nature 378, 563.
18. + cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nature Med 3, 659.
19. 19. MACIASZEK J.W., PARADA N.A., CRUIKSHANK W.W., CENTER D.M., KORNFELD H. & VIGLIANTI G.A. (1997) IL-16 represses HIV-1 promoter activity. J Immunol 158, 5.
20. 20. GAO M., TSUCHIE H., DETORIO M.A. et al. (1997) Interleukin-16 does not suppress HIV-1 replication in naturally infected peripheral blood mononucleur cells. AIDS 11, 538.
21. 21. KORNFELD H., CRUIKSHANK W.W., PYLE S.W., BERMAN J.S. & CENTER D.M. (1988) Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335, 445.
22. 1ck with CD4 in human T lymphocytes. J Biol Chem 266, 11176.
23. + T cells. J Biol Chem 270, 19364.
24. + T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 55, 285.
25. 25. CHIRMULE N., KALYANARAMAN V.S., OYAIZU N., SLADE H.B. & PAHWA S. (1990) Inhibition of functional properties of tetanus antigen-specific T cell clones by envelope glycoprotein gp120 of human immunodeficiency virus. Blood 75, 152.
26. 26. LIEGLER T.J. & STITES D.P. (1994) HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J Acquir Immune Defic Syndr 7, 340.
27. 27. THEODORE A.C., KORNFELD H., WALLACE R.P. & CRUIKSHANK W.W. (1994) CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. J Acquir Immune Defic Syndr 7, 899.
28. 28. SCHOLS D. & CLERCQ E.D. (1996) Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J Virol 70, 4953.
29. 29. BALDARI C.T., MILIA E., DI SOMMA M.M., BALDONI F., VALITUTTI S. & TELFORD J.L. (1995) Distinct signaling properties identify functionally different CD4 epitopes. Eur J Immunol 25, 1843.
30. 30. GELEZIUNAS R., BOUR S. & WAINBERG M.A. (1994) Cell surface down-modulation of CD4 after infection by HIV-1. FASEB 8, 593.
31. 31. BANDA N.K., BERNIER J., KURAHARA D.K. et al. (1992) Crosslinking CD4 by human immunodeficiency virus gp120 primers T cells for activation-induced apoptosis. J Exp Med 176, 1099.
32. 32. SEKIGAWA. I., HISHIKAWA H., KANEKO H. et al. (1994) FK506 can inhibit apoptotic cell death induced by the HIV-1 envelope glycoprotein gp120. AIDS 8, 1623.
33. 33. WESTENDORP M.O., FRANK R., OCHSENBAUER C. et al. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature 375, 497.
34. 34. CHACE J.H., COWDERY J.S. & FIELD E.H. (1994) Effect of anti-CD4 on CD4 subsets. J Immunol 152, 405.
35. 35. SEKIGAWA. I., KANEKO H., HISHIKAWA T. et al. (1998) HIV infection and SLE: their pathogenic relationship. Clin Exp Rheumatol 16, 175.
36. 36. LEE S., KANEKO H., SEKIGAWA. I., TOKANO Y., TAKASAKI T. & MASHIMOTO H. (1998) Circulating interleukin-16 in systemic lupus erythematosus. Br J Rheumatol (in press).